RocketTickers

Radius Announces Positive Phase 3 Topline Results for TYMLOS® (a

Long
NASDAQ:RDUS   Radius Recycling, Inc.
RDUS: Radius Health Inc.
2021-10-18 08:30:00
Radius Announces Positive Phase 3 Topline Results for TYMLOS® (abaloparatide) Subcutaneous Injection in Males with Osteoporosis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.